Search - tctmd.com

Displaying 421 - 440 of 7326

Sort: Relevancy | Date

Presentation NY Valves 2025

Recognizing When a Watchman Result is Not Good Enough: Making Sense of Shoulders, Gutters, Fabric Leaks, and Various Device Shapes

Presenter: Gagan D. Singh

June 26, 2025

Presentation NY Valves 2025

MonarQ TTVR System: Technology Update and Early Clinical Experience

Presenter: Arshad Quadri

June 26, 2025

Presentation NY Valves 2025

How To Determine the Optimal Transseptal Puncture Site for the Watchman Procedure

Presenter: Rodney Horton

June 26, 2025

Presentation NY Valves 2025

Clinical Progression in TRILUMINATE Pivotal Control Group: Insights Into Crossover to Tricuspid TEER

Presenter: Matthew J. Price

June 26, 2025

Presentation NY Valves 2025

Late Clinical Outcomes After TAVR: Impact of Frailty and Social Vulnerability in a “Real World” Administrative Claims Database

Presenter: Gregory P. Fontana

June 26, 2025

Presentation NY Valves 2025

Unexpected Migration of a MitraClip: Clinical Challenges and Lessons Learned

Presenter: Salman Khalid

June 26, 2025

Presentation NY Valves 2025

What Is the Evidence for Clinical Surveillance in Severe Aortic Stenosis?

Presenter: Sreekanth Vemulapalli

June 26, 2025

Presentation NY Valves 2025

Patient Selection for TTVR: Clinical/Physiologic Considerations

Presenter: Susheel K. Kodali

June 26, 2025

Presentation NY Valves 2025

Incidence and Clinical Implications of Conduction Disturbances After TAVR and Post Procedural Management

Presenter: Tamim M. Nazif

June 26, 2025

Presentation NY Valves 2025

How Many Clinical Phenotypes?

Presenter: Dharam J. Kumbhani

June 26, 2025

Presentation NY Valves 2025

Clip Laceration to Faciliate Transcatheter Tricsupid Valve Replacement (Evoque): When & How

Presenter: Pradeep K. Yadav

June 26, 2025

Presentation NY Valves 2025

What Are the Next Clinical Trials Needed in the Tricuspid Space?

Presenter: David J. Cohen

June 26, 2025

Presentation NY Valves 2025

The AMEND Transcatheter Mitral Valve Annuloplasty System: Early Human Clinical Experience (Valcare)

Presenter: Federico De Marco

June 26, 2025

Presentation NY Valves 2025

MAYBE, Lets Also Consider the OUS Registry Data

Presenter: Ralph Stephan von Bardeleben

June 26, 2025

Presentation NY Valves 2025

NO, Unblinded Patient-Reported Outcomes Are Simply Not Enough!

Presenter: Sanjay Kaul

June 26, 2025

Presentation NY Valves 2025

YES, in these Desperate Patients, Quality-of-Life Outcomes Are a Great Starting Point!

Presenter: Paul Sorajja

June 26, 2025

Presentation NY Valves 2025

Impact of Prolapse Gap and Width on Clinical Outcomes After Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation

Presenter: Naoki Nishiura

June 26, 2025

Presentation NY Valves 2025

A Deep Dive Into the Quality-of-Life Evidence From TRILUMINATE and TRISCEND II

Presenter: Suzanne V. Arnold

June 26, 2025

Presentation NY Valves 2025

Impact of Aortic Elastance on Hemodynamic and Clinical Outcomes After Transcatheter Edge-to-Edge Repair

Presenter: Habib Layoun

June 26, 2025

Presentation NY Valves 2025

Reviewing the Main Clinical Findings From Recent TTVI Clinical Trials

Presenter: Charles J. Davidson

June 26, 2025

Advertisement

Recognizing When a Watchman Result is Not Good Enough: Making Sense of Shoulders, Gutters, Fabric Leaks, and Various Device Shapes

MonarQ TTVR System: Technology Update and Early Clinical Experience

How To Determine the Optimal Transseptal Puncture Site for the Watchman Procedure

Clinical Progression in TRILUMINATE Pivotal Control Group: Insights Into Crossover to Tricuspid TEER

Late Clinical Outcomes After TAVR: Impact of Frailty and Social Vulnerability in a “Real World” Administrative Claims Database

Unexpected Migration of a MitraClip: Clinical Challenges and Lessons Learned

What Is the Evidence for Clinical Surveillance in Severe Aortic Stenosis?

Patient Selection for TTVR: Clinical/Physiologic Considerations

Incidence and Clinical Implications of Conduction Disturbances After TAVR and Post Procedural Management

How Many Clinical Phenotypes?

Clip Laceration to Faciliate Transcatheter Tricsupid Valve Replacement (Evoque): When & How

What Are the Next Clinical Trials Needed in the Tricuspid Space?

The AMEND Transcatheter Mitral Valve Annuloplasty System: Early Human Clinical Experience (Valcare)

MAYBE, Lets Also Consider the OUS Registry Data

NO, Unblinded Patient-Reported Outcomes Are Simply Not Enough!

YES, in these Desperate Patients, Quality-of-Life Outcomes Are a Great Starting Point!

Impact of Prolapse Gap and Width on Clinical Outcomes After Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation

A Deep Dive Into the Quality-of-Life Evidence From TRILUMINATE and TRISCEND II

Impact of Aortic Elastance on Hemodynamic and Clinical Outcomes After Transcatheter Edge-to-Edge Repair

Reviewing the Main Clinical Findings From Recent TTVI Clinical Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content